Colgate-Palmolive (NYSE:CL) Shares Sold by SouthState Corp

SouthState Corp cut its position in shares of Colgate-Palmolive (NYSE:CL) by 8.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,190 shares of the company’s stock after selling 468 shares during the quarter. SouthState Corp’s holdings in Colgate-Palmolive were worth $472,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp raised its stake in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC raised its position in Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock worth $2,095,325,000 after acquiring an additional 552,949 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after purchasing an additional 557,492 shares in the last quarter. Amundi grew its position in shares of Colgate-Palmolive by 12.8% in the fourth quarter. Amundi now owns 9,200,144 shares of the company’s stock valued at $806,015,000 after purchasing an additional 1,040,604 shares during the last quarter. Finally, Barclays PLC increased its stake in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.0 %

NYSE CL opened at $90.72 on Tuesday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The company’s 50 day moving average price is $89.09 and its 200 day moving average price is $94.56. The firm has a market capitalization of $73.62 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business posted $0.87 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently issued reports on CL. Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.